Agree Titus,
I also like
HSV-2 program
•1 in 6 people in the US estimated to be HSV positive
•Significant market size
•Estimated growth north of $6Bn with treatment/vaccine available
•No approved vaccine available
HPV program
•Still many people not using or completing the HPV vaccine therefore need
•~<35% vaccination rate for HPV in the US
•Current HPV vaccines do not treat the disease (people already infected)
•Estimated at greater than $1Bn market potential for therapeutic vaccine
Agree Titus,I also like HSV-2 program•1 in 6 people in the US...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
-0.500(3.19%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $294.3K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1135 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |